This study suggests that a combined model incorporating serum IGF-1, IGFBP-3, and the IGF-1/IGFBP-3 molar ratio may improve TN prediction for TNs in patients with T2DM. Here, IGFBP3 is linked to type 2 diabetes mellitus.